| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.43 | 4e-17 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-12 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.36 | 2e-11 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-11 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-07 |